Which are the causes of Wiedemann-Steiner Syndrome?

Wiedemann-Steiner Syndrome is a rare genetic condition caused by pathogenic variants (mutations) in the KMT2A gene, which plays a critical role in regulating gene expression during development. Because this mutation occurs in a gene essential for organ and brain development, it results in the multisystem symptoms characteristic of Wiedemann-Steiner Syndrome.

What causes Wiedemann-Steiner Syndrome at the genetic level?

Wiedemann-Steiner Syndrome is caused by a disruption in the KMT2A gene located on chromosome 11. This gene provides instructions for creating a protein that acts like a "master switch" for other genes, helping to organize how cells grow and specialize. When one copy of this gene is mutated or missing, the body cannot properly manage these developmental instructions, leading to the clinical features of Wiedemann-Steiner Syndrome.

Is Wiedemann-Steiner Syndrome hereditary?

In the vast majority of cases, Wiedemann-Steiner Syndrome occurs as a de novo (new) mutation. This means the genetic change happens spontaneously in the egg or sperm cell or during early embryonic development, rather than being inherited from a parent. Because it is rarely inherited, the risk of parents having another child with Wiedemann-Steiner Syndrome is generally very low, though clinical geneticists recommend formal testing for recurrence risk.

What are the primary factors in the etiology of the condition?

Understanding the etiology of Wiedemann-Steiner Syndrome requires distinguishing between genetic causes and environmental triggers. Current medical research highlights the following:

• Genetic Mutation: The primary cause is a heterozygous loss-of-function mutation in the KMT2A gene.


• No Known Environmental Triggers: There is no evidence that external environmental factors, such as maternal diet or chemical exposures, cause Wiedemann-Steiner Syndrome.


• Not an Autoimmune or Metabolic Disease: While patients may experience metabolic or developmental challenges, these are downstream effects of the initial genetic mutation, not independent disease processes.

How is research advancing our understanding?

Researchers are currently using advanced genomic sequencing to better understand how different types of KMT2A mutations correlate with the severity of Wiedemann-Steiner Syndrome. With 193 people with Wiedemann-Steiner Syndrome currently sharing their experiences on DiseaseMaps.org, community-driven data is helping clinicians map the natural history of the condition more accurately.

Next steps

• Consult a clinical geneticist for chromosomal microarray or whole-exome sequencing to confirm a diagnosis of Wiedemann-Steiner Syndrome.


• Connect with the DiseaseMaps.org community to share experiences with other families affected by Wiedemann-Steiner Syndrome.


• Request a referral to a pediatric specialist to manage the specific developmental needs associated with the syndrome.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Wiedemann-Steiner Syndrome.


• Online Mendelian Inheritance in Man (OMIM): Entry #605130 (Wiedemann-Steiner Syndrome).


• Orphanet: Rare Disease Database (ORPHA:3300).


• Wiedemann-Steiner Syndrome Foundation: Patient-centered clinical resources.